MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis
TSX:MDA - Toronto Stock Exchange - CA55293N1096 - Common Stock - Currency: CAD
MDA gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 12 industry peers in the Aerospace & Defense industry. MDA scores excellent on profitability, but there are some minor concerns on its financial health. MDA is growing strongly while it is still valued neutral. This is a good combination! These ratings could make MDA a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
In the past year MDA was profitable.
MDA had a positive operating cash flow in the past year.
Of the past 5 years MDA 4 years were profitable.
In the past 5 years MDA always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 3.46%, MDA belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
The Return On Equity of MDA (8.11%) is better than 91.67% of its industry peers.
MDA has a Return On Invested Capital of 5.93%. This is comparable to the rest of the industry: MDA outperforms 58.33% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MDA is below the industry average of 8.10%.
The 3 year average ROIC (3.99%) for MDA is below the current ROIC(5.93%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.46% | ||
| ROE | 8.11% | ||
| ROIC | 5.93% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
1.3 Margins
MDA's Profit Margin of 8.06% is amongst the best of the industry. MDA outperforms 91.67% of its industry peers.
In the last couple of years the Profit Margin of MDA has grown nicely.
MDA has a Operating Margin (10.38%) which is in line with its industry peers.
MDA's Operating Margin has improved in the last couple of years.
MDA's Gross Margin of 24.84% is fine compared to the rest of the industry. MDA outperforms 66.67% of its industry peers.
In the last couple of years the Gross Margin of MDA has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.38% | ||
| PM (TTM) | 8.06% | ||
| GM | 24.84% |
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MDA is destroying value.
Compared to 1 year ago, MDA has more shares outstanding
The debt/assets ratio for MDA has been reduced compared to a year ago.
2.2 Solvency
MDA has an Altman-Z score of 2.39. This is not the best score and indicates that MDA is in the grey zone with still only limited risk for bankruptcy at the moment.
With an excellent Altman-Z score value of 2.39, MDA belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
MDA has a debt to FCF ratio of 0.17. This is a very positive value and a sign of high solvency as it would only need 0.17 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.17, MDA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.10 indicates that MDA is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.10, MDA is doing good in the industry, outperforming 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 0.17 | ||
| Altman-Z | 2.39 |
ROIC/WACC0.65
WACC9.17%
2.3 Liquidity
A Current Ratio of 0.65 indicates that MDA may have some problems paying its short term obligations.
MDA has a worse Current ratio (0.65) than 83.33% of its industry peers.
A Quick Ratio of 0.64 indicates that MDA may have some problems paying its short term obligations.
MDA has a Quick ratio of 0.64. This is in the better half of the industry: MDA outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.65 | ||
| Quick Ratio | 0.64 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 120.00% over the past year.
MDA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 185.75% yearly.
MDA shows a strong growth in Revenue. In the last year, the Revenue has grown by 49.98%.
The Revenue has been growing by 31.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)120%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%163.64%
Revenue 1Y (TTM)49.98%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%67.86%
3.2 Future
The Earnings Per Share is expected to grow by 34.73% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 24.90% on average over the next years. This is a very strong growth
EPS Next Y69.97%
EPS Next 2Y42.72%
EPS Next 3Y34.73%
EPS Next 5YN/A
Revenue Next Year52.44%
Revenue Next 2Y31.83%
Revenue Next 3Y24.9%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 47.81, which means the current valuation is very expensive for MDA.
Compared to the rest of the industry, the Price/Earnings ratio of MDA is on the same level as its industry peers.
MDA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.41.
A Price/Forward Earnings ratio of 29.51 indicates a quite expensive valuation of MDA.
MDA's Price/Forward Earnings ratio is in line with the industry average.
MDA is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 33.87, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.81 | ||
| Fwd PE | 29.51 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MDA is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MDA indicates a rather cheap valuation: MDA is cheaper than 83.33% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.28 | ||
| EV/EBITDA | 22.76 |
4.3 Compensation for Growth
MDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MDA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as MDA's earnings are expected to grow with 34.73% in the coming years.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y42.72%
EPS Next 3Y34.73%
5. Dividend
5.1 Amount
No dividends for MDA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:MDA (8/11/2025, 7:00:00 PM)
42.07
-2.39 (-5.38%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners30.22%
Inst Owner ChangeN/A
Ins Owners1.25%
Ins Owner ChangeN/A
Market Cap5.25B
Analysts75
Price Target49.54 (17.76%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.13%
Min EPS beat(2)19.18%
Max EPS beat(2)21.08%
EPS beat(4)3
Avg EPS beat(4)21.89%
Min EPS beat(4)-9.44%
Max EPS beat(4)56.74%
EPS beat(8)7
Avg EPS beat(8)31.5%
EPS beat(12)10
Avg EPS beat(12)34.88%
EPS beat(16)13
Avg EPS beat(16)79.79%
Revenue beat(2)2
Avg Revenue beat(2)7.26%
Min Revenue beat(2)6.87%
Max Revenue beat(2)7.65%
Revenue beat(4)4
Avg Revenue beat(4)6%
Min Revenue beat(4)0.84%
Max Revenue beat(4)8.65%
Revenue beat(8)6
Avg Revenue beat(8)3.15%
Revenue beat(12)9
Avg Revenue beat(12)2.76%
Revenue beat(16)11
Avg Revenue beat(16)1.13%
PT rev (1m)39.34%
PT rev (3m)37.1%
EPS NQ rev (1m)0.53%
EPS NQ rev (3m)3.29%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.41%
Revenue NQ rev (3m)1.37%
Revenue NY rev (1m)1.63%
Revenue NY rev (3m)1.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.81 | ||
| Fwd PE | 29.51 | ||
| P/S | 4.3 | ||
| P/FCF | 6.28 | ||
| P/OCF | 4.96 | ||
| P/B | 4.32 | ||
| P/tB | 27.96 | ||
| EV/EBITDA | 22.76 |
EPS(TTM)0.88
EY2.09%
EPS(NY)1.43
Fwd EY3.39%
FCF(TTM)6.69
FCFY15.91%
OCF(TTM)8.48
OCFY20.15%
SpS9.79
BVpS9.74
TBVpS1.5
PEG (NY)0.68
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.46% | ||
| ROE | 8.11% | ||
| ROCE | 8.23% | ||
| ROIC | 5.93% | ||
| ROICexc | 7.84% | ||
| ROICexgc | 65.94% | ||
| OM | 10.38% | ||
| PM (TTM) | 8.06% | ||
| GM | 24.84% | ||
| FCFM | 68.38% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexcg growth 3Y59.28%
ROICexcg growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 0.17 | ||
| Debt/EBITDA | 0.55 | ||
| Cap/Depr | 237.75% | ||
| Cap/Sales | 18.19% | ||
| Interest Coverage | 6.47 | ||
| Cash Conversion | 479.99% | ||
| Profit Quality | 848.33% | ||
| Current Ratio | 0.65 | ||
| Quick Ratio | 0.64 | ||
| Altman-Z | 2.39 |
F-Score6
WACC9.17%
ROIC/WACC0.65
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)120%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%163.64%
EPS Next Y69.97%
EPS Next 2Y42.72%
EPS Next 3Y34.73%
EPS Next 5YN/A
Revenue 1Y (TTM)49.98%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%67.86%
Revenue Next Year52.44%
Revenue Next 2Y31.83%
Revenue Next 3Y24.9%
Revenue Next 5YN/A
EBIT growth 1Y91.69%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year177.81%
EBIT Next 3Y52.71%
EBIT Next 5YN/A
FCF growth 1Y975.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1100.79%
OCF growth 3Y124.48%
OCF growth 5YN/A